Abraham Chesed
CIK: 0002094374
Transaction Breakdown
Open Market Buys (P)1 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TTRX
Turn Therapeutics Inc.
Discretionary Trading P&L
Holdings
About Chesed Abraham
Chesed Abraham (SEC CIK 0002094374) files insider reports with the SEC as Turn Therapeutics Inc. (TTRX).
Signal8 holds 1 ownership filing by Chesed Abraham, a Form 4, filed on Oct 29, 2025. Those filings report 1 transaction, the latest on Oct 23, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Chesed Abraham's filings is in CALABASAS, CA.
Recent filings by Chesed Abraham
- Oct 23, 2025: Open-market purchase of TTRX shares (Form 4, code P).
Other insiders filing for Turn Therapeutics Inc. (TTRX)
- Dewhurst Martin William, Director
- Gengos Andrew, Director
- GOLDEN ARTHUR F, Director
- Kester Kent Edward, Director
- Burnam Bradley Evan, Chief Executive Officer
- Chaudhary Zuraiz